Research advances in cytomegalovirus hepatitis
10.3969/j.issn.1001-5256.2023.06.028
- VernacularTitle:巨细胞病毒性肝炎研究进展
- Author:
Qinghe ZENG
1
;
Yan MENG
2
;
Yuxiang LI
3
Author Information
1. Department of Infectious Diseases, Zaozhuang Maternal and Child Health Hospital, Zaozhuang, Shandong 277100, China
2. School of Medicine, Zaozhuang Vocational College, Zaozhuang, Shandong 277800, China
3. Department of Infectious Diseases, The First Hospital of Jilin University, Changchun 130021, China
- Publication Type:Review
- Keywords:
Cytomegalovirus Infections;
Hepatitis, Viral, Human;
Epidemiology;
Pathological Conditions, Signs and Symptoms;
Diagnosis;
Therapeutics
- From:
Journal of Clinical Hepatology
2023;39(6):1431-1439
- CountryChina
- Language:Chinese
-
Abstract:
Cytomegalovirus hepatitis is a liver disease caused by human cytomegalovirus infection and is one of the most common liver diseases in children and immunocompromised individuals. This disease has no specific clinical manifestations and is easily confused with other types of viral hepatitis, which may lead to delayed treatment or mistreatment. Therefore, the early diagnosis of cytomegalovirus hepatitis is of vital importance, and patients should be given timely and effective treatment with appropriately selected antiviral drugs and course of treatment. This article reviews the recent research advances in the etiology, epidemiology, pathogenesis, clinical manifestations, diagnosis, treatment, and prevention of cytomegalovirus hepatitis.
